2026 Seaborg Award: Henry VanBrocklin

Education: BS, Chemistry, and MS, Chemistry, Rensselaer Polytechnic Institute; PhD, Radiopharmaceutical Chemistry, Washington University in St. Louis

VanBrocklin on a memorable project: “I have two. The first is the development of radiolabeled fluoroestradiol analogs for breast cancer diagnostic imaging, a project that launched my career in radiopharmaceutical chemistry. The second, more recent, project is preparing radiolabeled agents to detect reservoirs of and immunological response to infectious diseases, notably HIV and COVID, to enable curative strategies.”

What VanBrocklin’s colleagues say: “Henry is a visionary scientist who has developed creative innovative approaches for the radiochemistry of new molecular imaging agents. His work is far reaching and impacts multiple disease states including Alzheimer’s disease, cancer, and HIV.”— Suzanne E. Lapi, University of Alabama at Birmingham